Technical Analysis for PTN - Palatin Technologies, Inc.

Grade Last Price % Change Price Change
grade F 0.701 -2.64% -0.02
PTN closed down 2.64 percent on Friday, January 18, 2019, on 55 percent of normal volume.
12 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PTN trend table...

Date Alert Name Type % Chg
Jan 18 Fell Below 20 DMA Bearish 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 17 20 DMA Support Bullish -2.64%
Jan 16 Crossed Above 20 DMA Bullish -2.64%
Jan 15 Fell Below 20 DMA Bearish -1.27%
Jan 15 Narrow Range Bar Range Contraction -1.27%
Jan 15 NR7 Range Contraction -1.27%
Jan 15 Down 3 Days in a Row Weakness -1.27%
Jan 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.64%
Jan 14 20 DMA Support Bullish -2.64%

Older signals for PTN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Is PTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 7 FDA action date for Palatin's Vyleesi extended to June 23
Dec 30 The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Dec 18 Palatin Technologies, Inc. (PTN): Hedge Fund Sentiment Unchanged
Nov 27 Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC — Emerging Consolidated Expectations, Analyst Ratings
Nov 19 Palatin Tech +8.8% as CEO, COO/CFO disclose share purchases
Nov 17 Here’s What Palatin Technologies Inc’s (NYSEMKT:PTN) P/E Ratio Is Telling Us
Nov 13 Edited Transcript of PTN earnings conference call or presentation 13-Nov-18 4:00pm GMT
Nov 13 What Kind Of Shareholders Own Palatin Technologies Inc (NYSEMKT:PTN)?
Nov 13 Palatin Techn down 3% on Q1 results
Nov 13 Palatin Tech beats by $0.01, misses on revenue
See more PTN news...
Indicators
Indicator Value
52 Week High 1.59
52 Week Low 0.59
Average Volume 985,708
200-Day Moving Average 0.9779
50-Day Moving Average 0.7559
20-Day Moving Average 0.719
10-Day Moving Average 0.7242
Average True Range 0.0452
ADX 23.3
+DI 17.4215
-DI 21.335
Chandelier Exit (Long, 3 ATRs ) 0.6844
Chandelier Exit (Short, 3 ATRs ) 0.7256
Upper Bollinger Band 0.7909
Lower Bollinger Band 0.6471
Percent B (%b) 0.37
BandWidth 20.0
MACD Line -0.01
MACD Signal Line -0.0108
MACD Histogram 0.0008
Fundamentals Value
Market Cap 125.51 Million
Num Shares 179 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -8.76
Price-to-Sales 3.03
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.75
Resistance 3 (R3) 0.76 0.75 0.74
Resistance 2 (R2) 0.75 0.73 0.74 0.74
Resistance 1 (R1) 0.72 0.73 0.72 0.72 0.74
Pivot Point 0.71 0.71 0.71 0.71 0.71
Support 1 (S1) 0.69 0.70 0.68 0.68 0.66
Support 2 (S2) 0.68 0.69 0.67 0.66
Support 3 (S3) 0.65 0.68 0.66
Support 4 (S4) 0.65